NASDAQ

Fate Therapeutics, Inc. (FATE)

♥ 606 Thanks from members

Live price chart, market sentiment, and community perspectives for Fate Therapeutics, Inc. (NASDAQ: FATE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: David SchafferFounder: Leonard ZonLeadership: Stefan Luzi (President and CEO)Leadership: Jorrit Ongena (Chief Medical Officer)Holder: Baker Bros. Advisors LPHolder: RA Capital ManagementHolder: Vanguard GroupFT516FT596FT819#FATE stock#Fate Therapeutics#cellular immunotherapy#CAR NK cells#biotech